Начало › Рак на белия дроб с недребноклетъчен тип › Илинойс › Evanston
Клинични проучвания за Рак на белия дроб с недребноклетъчен тип в Evanston, IL
22 проучвания за Рак на белия дроб с недребноклетъчен тип търсят участници в обекти в и около Evanston (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Набиране на участнициФаза 3
- NorthShore University HealthSystem-Evanston Hospital, Evanston
- NorthShore University HealthSystem-Glenbrook Hospital, Glenview · на 5 мили
- Advocate Lutheran General Hospital, Park Ridge · на 8 мили
- и още 1
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Набиране на участнициФаза 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · на 5 мили
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Набиране на участнициФаза 3
- Endeavor Health, Evanston
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Набиране на участнициФаза 3
- North Shore University Health System ( Site 4014), Evanston
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Набиране на участнициФаза 3
- Illinois Cancer Specialists, Niles · на 6 мили
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Набиране на участнициФаза 3
- Illinois Cancer Specialists, Niles · на 6 мили
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Набиране на участнициФаза 3
- Advocate Lutheran General Hospital, Park Ridge · на 8 мили
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Набиране на участнициФаза 2
- Illinois Cancer Specialists /ID# 274678, Niles · на 6 мили
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Набиране на участнициФаза 3
- Clinical Study Site, Evanston
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Набиране на участнициФаза 2/3
- USOR - Illinois Cancer Specialists - Niles, Niles · на 6 мили
- Advocate Medical Group Oncology, Park Ridge · на 8 мили
SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
Набиране на участнициНаблюдателно проучване
- Orchard Healthcare Research Inc., Skokie · на 2 мили
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Набиране на участнициФаза 3
- Orchard Healthcare Research Inc. ( Site 0115), Skokie · на 2 мили
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Набиране на участнициФаза 3
- Research Site, Niles · на 6 мили
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Набиране на участнициФаза 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · на 5 мили
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Набиране на участнициФаза 2
- Advocate Aurora Health, Park Ridge · на 8 мили
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Набиране на участнициФаза 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · на 5 мили
- Advocate Lutheran General Hospital, Park Ridge · на 8 мили
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Набиране на участнициФаза 3
- Research Site, Evanston
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Набиране на участнициФаза 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · на 5 мили
- Advocate Lutheran General Hospital, Park Ridge · на 8 мили
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Набиране на участнициФаза 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · на 5 мили
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Набиране на участнициФаза 2/3
- Northwestern Medicine Glenview Outpatient Center, Glenview · на 5 мили
- Advocate Lutheran General Hospital, Park Ridge · на 8 мили
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Набиране на участнициНаблюдателно проучване
- Advocate Lutheran General Hospital, Park Ridge · на 8 мили
GEMINI-NSCLC: NSCLC Biomarker Study
Набиране на участнициНаблюдателно проучване
- Northwestern University, Evanston
Проучвания за Рак на белия дроб с недребноклетъчен тип в други градове
- Houston, TX145 проучвания
- New York City, NY120 проучвания
- Arlington, VA104 проучвания
- Nashville, TN97 проучвания
- Boston, MA90 проучвания
- Los Angeles, CA87 проучвания
- St. Louis, MO73 проучвания
- Chicago, IL61 проучвания
- Baltimore, MD60 проучвания
- San Antonio, TX59 проучвания
- Columbus, OH56 проучвания
- Washington, DC55 проучвания
Други проучвания в Evanston
- Рак на белия дроб19 проучвания
- Рак на гърдата13 проучвания
- Остра миелоидна левкемия11 проучвания
- Затлъстяване11 проучвания
- Колоректален рак10 проучвания
- Рак (всички видове)9 проучвания
- Наднормено тегло9 проучвания
- Язвенен колит9 проучвания
- Рак на простатата9 проучвания
- Болест на Крон9 проучвания
- Сърдечна недостатъчност8 проучвания
- Предсърдно мъждене8 проучвания
От ClinicalTrials.gov, данни към 5.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.